Lobbying Relationship

Client

Apotex Corporation

More records

Lobbying firm

Brown Rudnick LLP

More records

  • Public Law 115-52, Section 808, relating to the Competitive Generic Therapy designation; President's FY19 budget proposal relating to generic drug 180-Day exclusivity

Duration: to

General Issues: Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Medicare/Medicaid, Pharmacy, Trade (Domestic & Foreign), Taxation/Internal Revenue Code

Spending: about $1,990,000 (But it's complicated. Here's why.)

Agencies lobbied since 2007: U.S. Senate, House of Representatives, U.S. Senate,, Congressional Budget Office (CBO), Federal Trade Commission (FTC), House of Representatives,

Related Foreign Entities: Shermfin, Inc. 150 Signet Drive (Weston, CAN); contribution to lobbying: $0; ownership 100%

Bills mentioned

H.R.2430: FDA Reauthorization Act of 2017

Sponsor: Greg Walden (R-Ore.)

S.934: FDA Reauthorization Act of 2017

Sponsor: Lamar Alexander (R-Tenn.)

H.R.2051: FAST Generics Act of 2017

Sponsor: David McKinley (R-W.Va.)

H.R.2212: CREATES Act of 2017

Sponsor: Tom Marino (R-Pa.)

S.974: Creating and Restoring Equal Access to Equivalent Samples Act of 2018

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.749: Lower Drug Costs through Competition Act

Sponsor: Kurt Schrader (D-Ore.)

S.3056: CREATES Act of 2016

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.34: 21st Century Cures Act

Sponsor: Suzanne Bonamici (D-Ore.)

H.R.9: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

S.131: FAIR Generics Act

Sponsor: David Vitter (R-La.)

S.2615: Increasing Competition in Pharmaceuticals Act

Sponsor: Susan Collins (R-Maine)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.2841: FAST Generics Act of 2015

Sponsor: Steve Stivers (R-Ohio)

H.R.5657: FAST Generics Act of 2014

Sponsor: Steve Stivers (R-Ohio)

H.R.5748: Medicaid Generic Drug Price Fairness Act of 2014

Sponsor: Elijah E. Cummings (D-Md.)

S.2948: Medicaid Generic Drug Price Fairness Act

Sponsor: Bernard Sanders (ID-Vt.)

H.R.3116: MODDERN Cures Act of 2013

Sponsor: Leonard Lance (R-N.J.)

S.504: FAIR Generics Act

Sponsor: Al Franken (D-Minn.)

S.214: Preserve Access to Affordable Generics Act

Sponsor: Amy Klobuchar (D-Minn.)

H.R.2725: Food and Drug Administration Safety Over Sequestration Act of 2013

Sponsor: Leonard Lance (R-N.J.)

H.R.3204: Drug Quality and Security Act

Sponsor: Fred Upton (R-Mich.)

S.959: Pharmaceutical Quality, Security, and Accountability Act

Sponsor: Tom Harkin (D-Iowa)

S.1882: FAIR Generics Act

Sponsor: Jeff Bingaman (D-N.M.)

H.R.4332: Generic Drug Application Review Fairness Act of 2012

Sponsor: Frank Pallone (D-N.J.)

H.R.5651: Food and Drug Administration Reform Act of 2012

Sponsor: Fred Upton (R-Mich.)

S.2516: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.2149: To designate the facility of the United States Postal Service located at...

Sponsor: Colleen Hanabusa (D-Hawaii)

S.1315: Drug Price Competition Act of 2009

Sponsor: Bill Nelson (D-Fla.)

H.R.3777: Drug Price Competition Act of 2009

Sponsor: Alcee L. Hastings (D-Fla.)

H.R.1706: Protecting Consumer Access to Generic Drugs Act of 2009

Sponsor: Bobby L. Rush (D-Ill.)

S.369: Preserve Access to Affordable Generics Act

Sponsor: Herb Kohl (D-Wis.)

H.R.4899: Supplemental Appropriations Act, 2010

Sponsor: David R. Obey (D-Wis.)

H.R.4213: Unemployment Compensation Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.759: Food and Drug Administration Globalization Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.3606: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Herb Kohl (D-Wis.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

S.501: Fair Prescription Drug Competition Act

Sponsor: John D. Rockefeller IV (D-W.Va.)

H.R.573: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the...

Sponsor: Jo Ann Emerson (R-Mo.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.726: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

S.1796: America's Healthy Future Act of 2009

Sponsor: Max Baucus (D-Mont.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.623: Pre-existing Condition Patient Protection Act of 2009

Sponsor: John D. Rockefeller IV (D-W.Va.)

H.R.6310: To amend the Internal Revenue Code of 1986 to require that the payment...

Sponsor: Ron Kind (D-Wis.)

H.R.6331: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.3610: Food and Drug Import Safety Act of 2007

Sponsor: John D. Dingell (D-Mich.)

S.1951: Fair Medicaid Drug Payment Act of 2007

Sponsor: Max Baucus (D-Mont.)

H.R.3700: Fair Medicaid Drug Payment Act of 2007

Sponsor: Frank Pallone (D-N.J.)

S.3101: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Max Baucus (D-Mont.)

S.316: Preserve Access to Affordable Generics Act

Sponsor: Herb Kohl (D-Wis.)

H.R.1432: Preserve Access to Affordable Generics Act

Sponsor: Henry A. Waxman (D-Calif.)

S.2476: Expanding Access to Low Cost Generic Drugs Act

Sponsor: Tina Smith (D-Minn.)

H.R.1892: Bipartisan Budget Act of 2018

Sponsor: John B. Larson (D-Conn.)

H.R.1625: Consolidated Appropriations Act, 2018

Sponsor: Edward Royce (R-Calif.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Henry Menn III CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95) CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995) CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commiss(93-95)
Lisa Layman SPA, Sen. Stabenow (05-07); SPA, Sen Graham(01-04); LA, Sen Bryan(00); LA, Sen Chafee(97-99); CBO, PA(92-96) SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996) SPA, Sen. Stabenow (05-07); SPA, Sen Graham(01-04); LA, Sen Bryan(00); LA, Sen Chafee (97-99); CBO, PA(92-96) CBO, PA(92-96); LA, Sen Chafee(97-99); LA, Sen Bryan(00); SPA, Sen Graham(01-04); SPA, Sen Stabenow(05-07)
ROBERT FOREMAN The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 to 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 to 2005) The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 to 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 to 2005) The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
Robert Forman SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
Robert Foreman III The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, 1993 to 2001 Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, 2001 to 2005
Christopher Bowlin Dep Asst Secr for Legisl, HHS, 08-09 Dep Asst Secr for Congr & Intgv Affairs, Dept. Labor 01-02 Prof Staff, House Cmte on Ed & Workforce 99-01
Rusty Ring Intern, Rep. Paris (83); Intern, Sen. Warner (83); Intern, Rep. Paris (84); LA, Rep. Paris (85-86)
Henry W Menn, III Mr. n/a
Michael Lewan Mr. n/a
Doyce Boesch Mr. n/a
Ruth Smith Ms. n/a
Jim Bonham Mr. n/a
Anne Fabry Ms. n/a
Marlene English Ms. n/a
Henry W Menn III n/a
Henry W. Menn III n/a
Chris Bowlin n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page